THIS PAGE IS INTENDED FOR THE GENERAL PUBLIC AND HEALTHCARE PROFESSIONALS
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you acknowledge that you are a patient based in the USA and will be redirected to a US product website that is independent of and not controlled by the owner of this website.
YES NOUKBED-N/A-2500047 / June 2025
You are leaving the Blue Earth Diagnostics corporate website. By clicking on one of these links, you accept that you are a US healthcare professional and will be taken to US promotional content that is independent and not controlled by the owner of this website.
ACCEPT and go to www.axumin.comACCEPT and go to www.posluma.com
NO, I AM A PATIENT OR MEMBER OF THE GENERAL PUBLIC
NO, I AM A NON-US HEALTHCARE PROFESSIONAL
CANCEL
UKBED-N/A-2500026 / May 2025
|
TRADEMARK
|
GENERIC NAME
|
PRODUCT AREA
|
LICENSED
|
PATIENTS
|
HCPs
|
|
Axumin |
fluciclovine F 18 injection |
Oncology |
US |
For patients based in the US, click here for more information |
For HCPs based in the US, click here for more information |
|
Axumin |
fluciclovine (18F) |
Oncology |
Europe, UK |
For patients based in Europe or the UK, click here and scroll down to see Patient Information Leaflets |
For HCPs based in Europe or the UK, click here and scroll down to see SmPCs, PILs and Image Interpretation Training Materials |
|
Posluma |
flotufolastat F 18 injection |
Oncology |
US |
For patients based in the US, click here for more information |
For HCPs based in the US, click here for more information |
UKBED-AX-2500004 / July 2025
